Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive genetic disorder that can cause severe anemia in affected individuals exposed to oxidative stress. This risk is particularly relevant in patients treated with the antimalarial drug primaquine. In Myanmar, primaquine has been widely administered as a Plasmodium vivax malaria treatment; however, prevalence of G6PD deficiency among the population remains insufficiently characterized. This study investigated the prevalence of G6PD variants among various minority ethnic subgroups residing in Kachin State, Myanmar. Blood samples from 440 participants were analyzed; however, the Mahidol variant (G487A) was identified in 21 individuals (4.8%). A major limitation of this study was the absence of G6PD enzyme activity data to confirm whether the Mahidol variant induces G6PD deficiency.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is caused by X-linked recessive disorderliness. It induces severe anemia when a patient with G6PD deficiency is exposed to oxidative stress that occurs with administration of an antimalarial drug, primaquine. The distribution of G6PD deficiency remains unknown while primaquine has been used for malaria treatment in Myanmar. This study aimed to investigate the prevalence of G6PD deficiency and its variants in Chin State, Myanmar. Among 322 participants, 18 (11 males and 7 females) demonstrated a G6PD deficiency. Orissa variant was dominant in the molecular analysis. This would be related to neighboring Indian and Bangladeshi population, in which Orissa variant was also reported as the main mutation type. The screening test for G6PD deficiency before primaquine treatment appears to be important in Myanmar.
Citations
Citations to this article as recorded by
Glucose-6-phosphate dehydrogenase variants in Kachin, Myanmar Zin Moon, Ja Moon Aung, Dorene VanBik, Hae Soo Yun, Sanghyun Lee, Sylvatrie-Danne Dinzouna-Boutamba, Zau Ring, Yeonchul Hong, Dong-Il Chung, Youn-Kyoung Goo Parasites, Hosts and Diseases.2025; 63(4): 360. CrossRef
Genetic diversity of Plasmodium falciparum erythrocyte membrane protein 1 in field isolates: Correspondence Amnuay Kleebayoon, Viroj Wiwanitkit Parasites, Hosts and Diseases.2023; 61(3): 338. CrossRef
Plasmodium lactate dehydrogenase (pLDH) is a strong target antigen for the determination of infection with Plasmodium species specifically. However, a more effective antibody is needed because of the low sensitivity of the current antibody in many immunological diagnostic assays. In this study, recombinant Plasmodium vivax LDH (PvLDH) was experimentally constructed and expressed as a native antigen to develop an effective P. vivax-specific monoclonal antibody (mAb). Two mAbs (2CF5 and 1G10) were tested using ELISA and immunofluorescence assays (IFA), as both demonstrated reactivity against pLDH antigen. Of the 2 antibodies, 2CF5 was not able to detect P. falciparum, suggesting that it might possess P. vivax-specificity. The detection limit for a pair of 2 mAbs-linked sandwich ELISA was 31.3 ng/ml of the recombinant antigen. The P. vivax-specific performance of mAbs-linked ELISA was confirmed by in vitro-cultured P. falciparum and P. vivax-infected patient blood samples. In conclusion, the 2 new antibodies possessed the potential to detect P. vivax and will be useful in immunoassay.
Citations
Citations to this article as recorded by
Diagnostic Methods for Non-Falciparum Malaria Alba Marina Gimenez, Rodolfo F. Marques, Matías Regiart, Daniel Youssef Bargieri Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Plasmodium falciparum Parasitemia and Band Sensitivity of the SD Bioline Malaria Ag P.f/Pan Rapid Diagnostic Test in Madagascar Rajeev K. Mehlotra, Rosalind E. Howes, Estee Y. Cramer, Riley E. Tedrow, Tovonahary A. Rakotomanga, Stéphanie Ramboarina, Arsène C. Ratsimbasoa, Peter A. Zimmerman
The American Journal of Tropical Medicine and Hygiene.2019; 100(5): 1196. CrossRef
To evaluate whether iron concentration in TYM medium influence on hydrogenosomal enzyme gene expression and hydrogenosomal membrane potential of Trichomonas vaginalis, trophozoites were cultivated in iron-depleted, normal and iron-supplemented TYM media. The mRNA of hydrogenosomal enzymes, such as pyruvate ferredoxin oxidoreductase (PFOR), hydrogenase, ferredoxin and malic enzyme, was increased with iron concentrations in T. vaginalis culture media, measured by RT-PCR. Hydrogenosomal membrane potentials measured with DiOC6 also showed similar tendency, e.g. T. vaginalis cultivated in iron-depleted and iron-supplemented media for 3 days showed a significantly reduced and enhanced hydrogenosomal membrane potential compared with that of normal TYM media, respectively. Therefore, it is suggested that iron may regulate hydrogenosomal activity through hydrogenosomal enzyme expression and hydrogenosomal membrane potential.
Citations
Citations to this article as recorded by
Molecular Targets Implicated in the Antiparasitic and Anti-Inflammatory Activity of the Phytochemical Curcumin in Trichomoniasis Natalia Mallo, Jesús Lamas, Rosa Ana Sueiro, José Manuel Leiro Molecules.2020; 25(22): 5321. CrossRef
Influence of 120 kDa Pyruvate:Ferredoxin Oxidoreductase on Pathogenicity of Trichomonas vaginalis Hyun-Ouk Song The Korean Journal of Parasitology.2016; 54(1): 71. CrossRef
Nitric oxide maintains cell survival of Trichomonas vaginalis upon iron depletion Wei-Hung Cheng, Kuo-Yang Huang, Po-Jung Huang, Jo-Hsuan Hsu, Yi-Kai Fang, Cheng-Hsun Chiu, Petrus Tang Parasites & Vectors.2015;[Epub] CrossRef
RNA-Binding Proteins in Trichomonas vaginalis: Atypical Multifunctional Proteins Elisa Figueroa-Angulo, Jaeson Calla-Choque, Maria Mancilla-Olea, Rossana Arroyo Biomolecules.2015; 5(4): 3354. CrossRef
Optimal Reference Genes for Gene Expression Normalization in Trichomonas vaginalis Odelta dos Santos, Graziela de Vargas Rigo, Amanda Piccoli Frasson, Alexandre José Macedo, Tiana Tasca, Robert W Dettman PLOS ONE.2015; 10(9): e0138331. CrossRef
Prostatic Disease Associated withTrichomonas vaginalis Jae-Sook Ryu The Korean Journal of Urogenital Tract Infection and Inflammation.2014; 9(2): 61. CrossRef
Hydrogenosome Metabolism Is the Key Target for Antiparasitic Activity of Resveratrol against Trichomonas vaginalis Natalia Mallo, Jesús Lamas, José M. Leiro Antimicrobial Agents and Chemotherapy.2013; 57(6): 2476. CrossRef
Responsiveness of Trichomonas vaginalis to iron concentrations: Evidence for a post-transcriptional iron regulation by an IRE/IRP-like system J.C. Torres-Romero, R. Arroyo Infection, Genetics and Evolution.2009; 9(6): 1065. CrossRef
Proinflammatory Cytokine and Nitric Oxide Production by Human Macrophages Stimulated with Trichomonas vaginalis Ik-Hwan Han, Sung Young Goo, Soon-Jung Park, Se-Jin Hwang, Yong-Seok Kim, Michael Sungwoo Yang, Myoung-Hee Ahn, Jae-Sook Ryu The Korean Journal of Parasitology.2009; 47(3): 205. CrossRef
Trichomonas vaginalis: The adhesins AP51 and AP65 bind heme and hemoglobin Shahed Ardalan, B. Craig Lee, Gary E. Garber Experimental Parasitology.2009; 121(4): 300. CrossRef
Trichomonas vaginalis‐induced neutrophil apoptosis causes anti‐inflammatory cytokine production by human monocyte‐derived macrophages M. H. AHN, H. O. SONG, J. S. RYU Parasite Immunology.2008; 30(8): 410. CrossRef
First
Prev
